MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 39, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-03
DOI
10.1186/s13046-020-01600-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 4-miRNA Score Predicts the Individual Metastatic Risk of Renal Cell Carcinoma Patients
- (2019) Joana Heinzelmann et al. ANNALS OF SURGICAL ONCOLOGY
- Multiple metastases of clear-cell renal cell carcinoma to different region of the nasal cavity and paranasal sinus 3 times successively
- (2018) Na Zhang et al. MEDICINE
- A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97
- (2018) João Ramalho-Carvalho et al. Clinical Epigenetics
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Profiling DNA Methylation Based on Next-Generation Sequencing Approaches: New Insights and Clinical Applications
- (2018) Daniela Barros-Silva et al. Genes
- The biological roles and clinical implications of microRNAs in clear cell renal cell carcinoma
- (2017) Ying-hua He et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer
- (2017) João Ramalho-Carvalho et al. Journal of Hematology & Oncology
- MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors
- (2017) Jorge Torres-Ferreira et al. Molecular Cancer
- Promoter DNA methylation analysis reveals a combined diagnosis of CpG-based biomarker for prostate cancer
- (2017) Yuanyuan Tang et al. Oncotarget
- miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma
- (2017) LongJiao Ran et al. Biomed Research International
- Renal cell carcinoma
- (2017) James J. Hsieh et al. Nature Reviews Disease Primers
- Increased Plasma miRNA-30a as a Biomarker for Non-Small Cell Lung Cancer
- (2016) Ling Sun et al. MEDICAL SCIENCE MONITOR
- MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib
- (2015) Bing Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Diagnostic and prognostic epigenetic biomarkers in cancer
- (2015) Pedro Costa-Pinheiro et al. Epigenomics
- MicroRNAs with Prognostic Potential for Metastasis in Clear Cell Renal Cell Carcinoma: A Comparison of Primary Tumors and Distant Metastases
- (2013) Joana Heinzelmann et al. ANNALS OF SURGICAL ONCOLOGY
- Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma
- (2013) K Gebauer et al. BRITISH JOURNAL OF CANCER
- MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis
- (2013) R M Silva-Santos et al. BRITISH JOURNAL OF CANCER
- Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4
- (2013) Qing Bo Huang et al. PLoS One
- Urine microRNAs as potential noninvasive biomarkers in urologic cancers
- (2013) Hana Mlcochova et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Circulating and Urinary microRNAs in Kidney Disease
- (2012) J. M. Lorenzen et al. Clinical Journal of the American Society of Nephrology
- Epidemiology, Aetiology, and Pathogenesis of Renal Cell Carcinoma
- (2012) Chris Protzel et al. EUROPEAN UROLOGY SUPPLEMENTS
- Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis
- (2012) Xiwei Wu et al. PLoS One
- Epigenetic biomarkers in urological tumors: A systematic review
- (2011) Carmen Jerónimo et al. CANCER LETTERS
- Non-coding RNAs in human disease
- (2011) Manel Esteller NATURE REVIEWS GENETICS
- Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma
- (2011) Joana Heinzelmann et al. WORLD JOURNAL OF UROLOGY
- High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions
- (2010) Ana Teresa Martins et al. BREAST CANCER RESEARCH AND TREATMENT
- Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma
- (2010) M A T Hildebrandt et al. ONCOGENE
- Regulation of MicroRNA Biogenesis: A miRiad of mechanisms
- (2009) Brandi N Davis et al. Cell Communication and Signaling
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started